INHIBITOR OF COMPLEMENT FACTOR B

Provided in the present disclosure is an inhibitor of the complement factor B. The structure of the inhibitor of the complement factor B is substantially as represented by general formula (I), and the definition of each substituent in the formula is as described in the description. The compound prov...

Full description

Saved in:
Bibliographic Details
Main Authors ZHAO, Tingli, WU, Jian, LIU, Jiang, MIAO, Lei, LI, Xuefei, MA, Changyou, SU, Jincai, JI, Xiaojun
Format Patent
LanguageChinese
English
French
Published 18.07.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided in the present disclosure is an inhibitor of the complement factor B. The structure of the inhibitor of the complement factor B is substantially as represented by general formula (I), and the definition of each substituent in the formula is as described in the description. The compound provided in the present invention has significant inhibitory activity on complement factor B, and can be used for preventing and/or treating a disease or disease state mediated by the inhibitor of the complement factor B. La présente invention concerne un inhibiteur du facteur B du complément. La structure de l'inhibiteur du facteur B du complément est sensiblement telle que représentée par la formule générale (I), et la définition de chaque substituant dans la formule est telle que décrite dans la description. Le composé selon la présente invention présente une activité inhibitrice significative sur le facteur B du complément, et peut être utilisé pour prévenir et/ou traiter une maladie ou un état pathologique médié p
Bibliography:Application Number: WO2024CN71419